Post-natal corticosteroids are associated with reduced expiratory flows in children born very preterm

Journal of Paediatrics and Child Health

Volumn 47, Issue 7, 2011, Pages 448-454

  Smith, Lucia J ^a,b   Van Asperen, Peter P ^a,b   McKay, Karen O ^a,b   Selvadurai, Hiran ^a,b   Fitzgerald, Dominic A ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

Author keywords

bronchopulmonary dysplasia; corticosteroid; outcome; prematurity; spirometry

Indexed keywords

CORTICOSTEROID; OXYGEN;

ARTICLE; ASSISTED VENTILATION; CHILD; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PEAK EXPIRATORY FLOW; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; SCHOOL CHILD; SPIROMETRY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; BRONCHOPULMONARY DYSPLASIA; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LINEAR MODELS; MALE; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGICAL PHENOMENA; RETROSPECTIVE STUDIES;

EID: 79960707224     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01992.x     Document Type: Article

References (42)

1. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen C, Milligan J,. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985; 76: 145-53. (Pubitemid 15039894)
2. Kwong M, Egan E, Notter R, Shapiro D,. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985; 76: 585-92. (Pubitemid 15248235)
3. Liggins G, Howie R,. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-25.
4. Crowther C, Haslam R, Hiller J, Doyle L, Robinson J, for the Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006; 367: 1913-9. (Pubitemid 43831995)
5. Jobe A,. Indications for and questions about antenatal steroids. In:, Barness LA, ed. Advances in Pediatrics, Vol. 49. St Louis, MO: Mosby Inc., 2002; 227-43.
6. Hack M, Friedman H, Faranoff A,. Outcomes of extremely low birthweight infants. Pediatrics 1996; 98: 931-7. (Pubitemid 26398778)
7. Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E,. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-32.
8. Jobe A, Bancalari E,. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723-9. (Pubitemid 32578778)
9. Chan K, Noble-Jamieson C, Elliman A, Bryan E, Silverman M,. Lung function in children of low birth weight. Arch. Dis. Child. 1989; 64: 1284-93. (Pubitemid 19220776)
10. Gross S, Iannuzzi D, Kveselis D, Anbar R,. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J. Pediatr. 1998; 133: 188-92. (Pubitemid 28385193)
11. Doyle L, Chavasse R, Ford G, Olinsky A, Davis N, Callanan C,. Changes in lung function between age 8 and 14 years in children with birth weight of less than 1501g. Pediatr. Pulmonol. 1999; 27: 185-90. (Pubitemid 29157620)
12. Anand D, Stevenson C, West C, Pharoah P,. Lung function and respiratory health in adolescents of very low birth weight. Arch. Dis. Child. 2003; 88: 135-8. (Pubitemid 36160641)
13. Kilbride H, Gelatt M, Sabath R,. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. J. Pediatr. 2003; 143: 488-93. (Pubitemid 37352508)
14. Doyle L, Victorian Infant Collaborative Study Group. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatr. Pulmonol. 2006; 41: 570-6. (Pubitemid 43801027)
15. Vrijlandt E, Gerritsen J, Boezen H, Grevink R, Duiverman E,. Lung function and exercise capacity in young adults born prematurely. Am. J. Respir. Crit. Care Med. 2006; 173: 890-6.
16. Baraldi E, Filippone M,. Chronic lung disease after premature birth. N. Engl. J. Med. 2007; 357: 1946-55. (Pubitemid 350074689)
17. Northway WJ, Moss R, Carlisle K, et al,. Late pulmonary sequelae of bronchopulmonary dysplasia. N. Engl. J. Med. 1990; 323: 1793-9.
18. Jacob S, Coates A, Lands L, et al,. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J. Pediatr. 1998; 133: 171-2.
19. Watterberg K,. Postnatal steroids for bronchopulmonary dysplasia: where are we now? J. Pediatr. 2007; 150: 327-8. (Pubitemid 46428301)
20. Shah V, Ohlsson A,. Postnatal dexamethasone in the prevention of chronic lung disease. Recent Adv. Paediatr. 2003; 19: 77-96.
21. Doyle L, Halliday H, Ehrenkranz R, Davis P, Sinclair J,. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005; 115: 655-61. (Pubitemid 43373025)
22. Gross S, Anbar R, Mettelman B,. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 2005; 115: 681-7. (Pubitemid 43373029)
23. Doyle L, Davis P, Morley C, McPhee A, Carlin J, the DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 2006; 117: 75-83. (Pubitemid 46050522)
24. Nixon P, Washburn L, Schechter M, O'Shea TM,. Follow up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at 8 to 11 years of age. J. Pediatr. 2007; 150: 345-50. (Pubitemid 46428295)
25. Centre for Epidemiology and Research, NSW Department of Health. Mothers and babies 2001. N.S.W. Public Health Bull. 2002; 13 (S-4): 23-45.
26. Smith L, Van Asperen P, McKay K, Selvadurai H, Fitzgerald D,. Reduced exercise capacity in children born very preterm. Pediatrics 2008; 122: e287-93.
27. Asher M, Keil U, Anderson H,. International Study of Asthma and Allergies in Childhood [ISAAC]: rationale and methods. Eur. Respir. J. 1995; 8: 483-91.
28. Allen J, Zwerdling R, Ehrenkranz R, et al,. Statement on the care of the child with chronic lung disease of infancy and childhood. Am. J. Respir. Crit. Care Med. 2003; 168: 356-96.
29. Peat J, Barton B,. Medical Statistics: A Guide to Data Analysis and Critical Appraisal, 1st edn. Oxford, UK: Blackwell Publishing Ltd., 2005.
30. American Thoracic Society. Standardization of spirometry 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
31. Munro B,. Statistical Methods for Health Care Research, 4th edn. London, UK: Lippincott Williams & Wilkins, 2002.
32. Pianosi P, Fisk M,. Cardiopulmonary exercise performance in prematurely born children. Pediatr. Res. 2000; 47: 653-8. (Pubitemid 30249855)
33. Northway WJ, Rosen R, Porter D,. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N. Engl. J. Med. 1967; 276: 357-68.
34. MacLean J, Fitzgerald D,. A rational approach to home oxygen use in infants and children. Paediatr. Respir. Rev. 2006; 7: 215-22. (Pubitemid 44294137)
35. Filippone M, Sartor M, Zacchello F, Baraldi E,. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 2003; 361: 753-4. (Pubitemid 36293632)
36. Ehrenkranz R, Walsh M, Vohr B, et al,. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-60. (Pubitemid 46056482)
37. Hjalmarson O, Sandberg K,. Lung function at term reflects severity of bronchopulmonary dysplasia. J. Pediatr. 2005; 146: 86-90. (Pubitemid 40091736)
38. Dalziel S, Rea H, Walker N, et al,. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax 2006; 61: 678-83. (Pubitemid 44211774)
39. American Academy of Pediatrics, Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-8.
40. Murphy B, Inder T, Huppi P, et al,. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001; 107: 217-21. (Pubitemid 32121232)
41. Colvin M, McGuire W, Fowlie P,. Neurodevelopmental outcomes after preterm birth. BMJ 2004; 329: 1390-3. (Pubitemid 39656364)
42. Yeh T, Lin Y, Lin H, et al,. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 2004; 350: 1304-13. (Pubitemid 38375365)